Kitoxan®
home > Kitoxan®
Kitoxan® by Latoxan
The first natural library of venom fractions for Drug Discovery and High Throughput Screening (HTS).
Kitoxan Kitoxan V01 Kitoxan V02 Kitoxan V03 Kitoxan V04
<< Back to Kitoxan V04

Search : `Naja haje` - PubMed Results: 116
  1. Therapeutic potency of kaempferol against Naja haje venom induced neurotoxicity, inflammation, biological activities, and antioxidant system damage: a pre-clinical antivenom evaluation.
    Ajisebiola BS, Adeniyi BD, Alakoso MO, Fapohunda ST, Nwanze KI, Adeyi AO
    Naunyn Schmiedebergs Arch Pharmacol 2024 Dec 2; PMID:39621086 PubMed - as supplied by publisher

  2. Envenomation with Snake Venoms as a Cause of Death: A Forensic Investigation of the Decomposition Stages and the Impact on Differential Succession Pattern of Carcass-Attracted Coleopteran Beetles.
    Khalil A, Salem AM, Shaurub EH, Ahmed AM, Al-Khalaf AA, Zidan MM
    Insects 2024 Nov 18;15(11) PMID:39590501 PubMed

  3. Neutralizing Nanobodies against Venoms from Naja haje Species Captured in North Africa.
    Mejri H, Mokrani R, Ksouri A, Seddik M, Awad N, Ayme G, Chagour T, Mokrani A, Louchene CE, Salhi I, Ben Abderrazek R, Khalifa RB, Benlasfar Z, Corringer PJ, Hammadi M, Djilani S, Lafaye P, Bouhaouala-Zahar B
    Toxins (Basel) 2024 Sep 14;16(9) PMID:39330851 PubMed - indexed for MEDLINE

  4. Investigating Snake-Venom-Induced Dermonecrosis and Inflammation Using an Ex Vivo Human Skin Model.
    Alsolaiss J, Leeming G, Da Silva R, Alomran N, Casewell NR, Habib AG, Harrison RA, Modahl CM
    Toxins (Basel) 2024 Jun 17;16(6) PMID:38922170 PubMed - indexed for MEDLINE

  5. Candida auris from the Egyptian cobra: Role of snakes as potential reservoirs.
    Cafarchia C, Mendoza-Roldan JA, Rhimi W, C I Ugochukwu I, Miglianti M, Beugnet F, Giuffrè L, Romeo O, Otranto D
    Med Mycol 2024 Jul 4;62(7) PMID:38816207 PubMed - indexed for MEDLINE

  6. Anticancer potency of Egyptian venom snakes on MCF-7 and HepG2 carcinoma cells.
    Abdallah S, Abdel-Halim KY, Alm-Eldeen A
    Environ Anal Health Toxicol 2024 Mar;39(1):e2024001-0 PMID:38631393 PubMed

  7. Exploration of antimicrobial and anticancer activities of L-amino acid oxidase from Egyptian Naja haje venom.
    Salama WH, Abd-Rabou AA, Bassuiny RI, El Hakim AE, Shahein YE
    Toxicon 2024 May 6;242:107708 PMID:38574827 PubMed - indexed for MEDLINE

  8. Acetylcholine-Binding Protein Affinity Profiling of Neurotoxins in Snake Venoms with Parallel Toxin Identification.
    Palermo G, Schouten WM, Alonso LL, Ulens C, Kool J, Slagboom J
    Int J Mol Sci 2023 Nov 26;24(23) PMID:38069093 PubMed - indexed for MEDLINE

  9. Intrageneric cross-reactivity of monospecific rabbit antisera against venoms of the medically most important Naja spp. African snakes.
    Gómez A, Sánchez A, Durán G, Villalta M, Segura Á, Vargas M, Solano D, Herrera M, Sánchez M, Gutiérrez JM, León G
    PLoS Negl Trop Dis 2023 Aug;17(8):e0011545 PMID:37582064 PubMed - indexed for MEDLINE

  10. Description of trunk neural crest migration and peripheral nervous system formation in the Egyptian cobra Naja haje haje.
    Khannoon ER, Alvarado C, Poveda R, de Bellard ME
    Differentiation 2023 Sep-Oct;133:40-50 PMID:37473561 PubMed - indexed for MEDLINE

  11. Assessing the Efficacy of Monovalent and Commercialized Antivenoms for Neutralizing Moroccan Cobra Naja haje Venom: A Comparative Study.
    Khourcha S, Hilal I, Elbejjaj I, Karkouri M, Safi A, Hmyene A, Oukkache N
    Trop Med Infect Dis 2023 Jun 2;8(6) PMID:37368722 PubMed

  12. Antibacterial Activity of Venom from the Puff Adder (Bitis arietans), Egyptian Cobra (Naja haje), and Red Spitting Cobra (Naja pallida).
    Okumu MO, Eyaan KL, Bett LK, Gitahi N
    Int J Microbiol 2023;2023:7924853 PMID:36908982 PubMed

  13. Membrane-Disrupting Activity of Cobra Cytotoxins Is Determined by Configuration of the N-Terminal Loop.
    Dubovskii PV, Ignatova AA, Alekseeva AS, Starkov VG, Boldyrev IA, Feofanov AV, Utkin YN
    Toxins (Basel) 2022 Dec 20;15(1) PMID:36668826 PubMed - indexed for MEDLINE

  14. Spatial Venomics?Cobra Venom System Reveals Spatial Differentiation of Snake Toxins by Mass Spectrometry Imaging.
    Hempel BF, Damm M, Petras D, Kazandjian TD, Szentiks CA, Fritsch G, Nebrich G, Casewell NR, Klein O, Süssmuth RD
    J Proteome Res 2023 Jan 6;22(1):26-35 PMID:36521429 PubMed - indexed for MEDLINE

  15. A Combined Bioassay and Nanofractionation Approach to Investigate the Anticoagulant Toxins of Mamba and Cobra Venoms and Their Inhibition by Varespladib.
    Arrahman A, Kazandjian TD, Still KBM, Slagboom J, Somsen GW, Vonk FJ, Casewell NR, Kool J
    Toxins (Basel) 2022 Oct 27;14(11) PMID:36355986 PubMed - indexed for MEDLINE

  16. Impact of Envenomation With Snake Venoms on Rabbit Carcass Decomposition and Differential Adult Dipteran Succession Patterns.
    Khalil A, Zidan MMM, Alajmi R, Ahmed AM
    J Med Entomol 2023 Jan 12;60(1):40-50 PMID:36354264 PubMed - indexed for MEDLINE

  17. Egyptian cobra (Naja haje haje) venom phospholipase A2: a promising antiviral agent with potent virucidal activity against simian rotavirus and bovine coronavirus.
    Salama WH, Shaheen MNF, Shahein YE
    Arch Microbiol 2022 Jul 27;204(8):526 PMID:35895237 PubMed - indexed for MEDLINE

  18. Concerted hepatoprotective effect of bradykinin potentiating factor and low dose of ?- radiation on Naja haje envenomed rats via Bax/Bcl2 pathway.
    Hasan HF, Mostafa DM, Lotfy DM
    Toxicol Mech Methods 2022 Jan;32(1):67-76 PMID:34353221 PubMed - indexed for MEDLINE

  19. Anti-Cancer Effect of Moroccan Cobra Naja haje Venom and Its Fractions against Hepatocellular Carcinoma in 3D Cell Culture.
    Lafnoune A, Lee SY, Heo JY, Gourja I, Darkaoui B, Abdelkafi-Koubaa Z, Chgoury F, Daoudi K, Chakir S, Cadi R, Mounaji K, Srairi-Abid N, Marrakchi N, Shum D, Seo HR, Oukkache N
    Toxins (Basel) 2021 Jun 4;13(6) PMID:34199838 PubMed - indexed for MEDLINE

  20. Proteomic analysis of three medically important Nigerian Naja (Naja haje, Naja katiensis and Naja nigricollis) snake venoms.
    Adamude FA, Dingwoke EJ, Abubakar MS, Ibrahim S, Mohamed G, Klein A, Sallau AB
    Toxicon 2021 Jul 15;197:24-32 PMID:33775665 PubMed - indexed for MEDLINE

  21. Moringa oleifera leaf fractions attenuated Naje haje venom-induced cellular dysfunctions via modulation of Nrf2 and inflammatory signalling pathways in rats.
    Adeyi AO, Ajisebiola BS, Adeyi OE, Adekunle O, Akande OB, James AS, Ajayi BO, Yusuf PO, Idowu BA
    Biochem Biophys Rep 2021 Mar;25:100890 PMID:33521334 PubMed

  22. A Neurotoxic Snake Venom without Phospholipase A(2): Proteomics and Cross-Neutralization of the Venom from Senegalese Cobra, Naja senegalensis (Subgenus: Uraeus).
    Wong KY, Tan KY, Tan NH, Tan CH
    Toxins (Basel) 2021 Jan 14;13(1) PMID:33466660 PubMed - indexed for MEDLINE

  23. Interspecific and intraspecific venom enzymatic variation among cobras (Naja sp. and Ophiophagus hannah).
    Modahl CM, Roointan A, Rogers J, Currier K, Mackessy SP
    Comp Biochem Physiol C Toxicol Pharmacol 2020 Jun;232:108743 PMID:32194156 PubMed - indexed for MEDLINE

  24. A Decoy-Receptor Approach Using Nicotinic Acetylcholine Receptor Mimics Reveals Their Potential as Novel Therapeutics Against Neurotoxic Snakebite.
    Albulescu LO, Kazandjian T, Slagboom J, Bruyneel B, Ainsworth S, Alsolaiss J, Wagstaff SC, Whiteley G, Harrison RA, Ulens C, Kool J, Casewell NR
    Front Pharmacol 2019;10:848 PMID:31417406 PubMed

  25. Distinctive Distribution of Secretory Phospholipases A? in the Venoms of Afro-Asian Cobras (Subgenus: Naja, Afronaja, Boulengerina and Uraeus).
    Tan CH, Wong KY, Tan NH, Ng TS, Tan KY
    Toxins (Basel) 2019 Feb 14;11(2) PMID:30769779 PubMed - indexed for MEDLINE

  26. Synthetic peptide antigens derived from long-chain alpha-neurotoxins: Immunogenicity effect against elapid venoms.
    de la Rosa G, Pastor N, Alagón A, Corzo G
    Peptides 2017 Feb;88:80-86 PMID:28010961 PubMed - indexed for MEDLINE

  27. Molecular modeling and structural analysis of nAChR variants uncovers the mechanism of resistance to snake toxins.
    Gunasekaran D, Sridhar J, Suryanarayanan V, Manimaran NC, Singh SK
    J Biomol Struct Dyn 2017 Jun;35(8):1654-1671 PMID:27421773 PubMed - indexed for MEDLINE

  28. Assessment of the Antimicrobial Activity of Few Saudi Arabian Snake Venoms.
    Al-Asmari AK, Abbasmanthiri R, Abdo Osman NM, Siddiqui Y, Al-Bannah FA, Al-Rawi AM, Al-Asmari SA
    Open Microbiol J 2015;9:18-25 PMID:26668657 PubMed

  29. Unique features of myogenesis in Egyptian cobra (Naja haje) (Squamata: Serpentes: Elapidae).
    Khannoon ER, Rupik W, Lewandowski D, Dubi?ska-Magiera M, Swad?ba E, Daczewska M
    Protoplasma 2016 Mar;253(2):625-33 PMID:26025263 PubMed - indexed for MEDLINE

  30. The development of the skull of the Egyptian Cobra Naja h. haje (Squamata: Serpentes: Elapidae).
    Khannoon ER, Evans SE
    PLoS One 2015;10(4):e0122185 PMID:25860015 PubMed - indexed for MEDLINE

  31. Protective effects of melatonin against oxidative damage induced by Egyptian cobra (Naja haje) crude venom in rats.
    Abdel Moneim AE, Ortiz F, Leonardo-Mendonça RC, Vergano-Villodres R, Guerrero-Martínez JA, López LC, Acuña-Castroviejo D, Escames G
    Acta Trop 2015 Mar;143:58-65 PMID:25542296 PubMed - indexed for MEDLINE

  32. Hepatotoxicity and oxidative stress induced by Naja haje crude venom.
    Al-Quraishy S, Dkhil MA, Abdel Moneim AE
    J Venom Anim Toxins Incl Trop Dis 2014;20(1):42 PMID:25258623 PubMed

  33. Evaluation of the lethal potency of scorpion and snake venoms and comparison between intraperitoneal and intravenous injection routes.
    Oukkache N, El Jaoudi R, Ghalim N, Chgoury F, Bouhaouala B, Mdaghri NE, Sabatier JM
    Toxins (Basel) 2014 Jun 12;6(6):1873-81 PMID:24926799 PubMed - indexed for MEDLINE

  34. [Which antivenom for Cerastes envenoming?].
    Mion G, Larréché S
    Med Sante Trop 2014 Jan-Mar;24(1):105-6 PMID:24736220 PubMed - indexed for MEDLINE

  35. Proteomic analysis of Moroccan cobra Naja haje legionis venom using tandem mass spectrometry.
    Malih I, Ahmad rusmili MR, Tee TY, Saile R, Ghalim N, Othman I
    J Proteomics 2014 Jan 16;96:240-52 PMID:24269350 PubMed - indexed for MEDLINE

  36. Identification and discrimination of snake venoms from Egyptian elapids.
    Ibrahim NM, El-Kady EM, Katamesh RA, El-Borei IH, Wahby AF
    Toxicon 2013 Mar 1;63:88-97 PMID:23220490 PubMed - indexed for MEDLINE

  37. Scales microstructure of snakes from the Egyptian area.
    Allam AA, Abo-Eleneen RE
    Zoolog Sci 2012 Nov;29(11):770-5 PMID:23106563 PubMed - indexed for MEDLINE

  38. Cross-neutralisation of the neurotoxic effects of Egyptian cobra venom with commercial tiger snake antivenom.
    Kornhauser R, Isbister GK, O'Leary MA, Mirtschin P, Dunstan N, Hodgson WC
    Basic Clin Pharmacol Toxicol 2013 Feb;112(2):138-43 PMID:22788931 PubMed - indexed for MEDLINE

  39. Molecular cloning and characterization of a complement-depleting factor from king cobra, Ophiophagus hannah.
    Zeng L, Sun QY, Jin Y, Zhang Y, Lee WH, Zhang Y
    Toxicon 2012 Sep 1;60(3):290-301 PMID:22561424 PubMed - indexed for MEDLINE

  40. Purification and characterization of a cytotoxic neurotoxin-like protein from Naja haje haje venom that induces mitochondrial apoptosis pathway.
    El Hakim AE, Gamal-Eldeen AM, Shahein YE, Mansour NM, Wahby AF, Abouelella AM
    Arch Toxicol 2011 Aug;85(8):941-52 PMID:21240479 PubMed - indexed for MEDLINE

  41. A new type of thrombin inhibitor, noncytotoxic phospholipase A2, from the Naja haje cobra venom.
    Osipov AV, Filkin SY, Makarova YV, Tsetlin VI, Utkin YN
    Toxicon 2010 Feb-Mar;55(2-3):186-94 PMID:19622365 PubMed - indexed for MEDLINE

  42. Assessment of the anti-Naja haje antibodies elicited in a low dose multi-site immunization protocol.
    El-Kady EM, Ibrahim NM, Wahby AF
    Toxicon 2009 Sep 15;54(4):450-9 PMID:19464310 PubMed - indexed for MEDLINE

  43. Actions of snake neurotoxins on an insect nicotinic cholinergic synapse.
    Hue B, Buckingham SD, Buckingham D, Sattelle DB
    Invert Neurosci 2007 Sep;7(3):173-8 PMID:17710455 PubMed - indexed for MEDLINE

  44. Redescription of Haemoproteus mesnili (Apicomplexa: Plasmodiidae) and its meronts, with description of a second haemosporidian parasite of African cobras.
    Telford SR Jr
    J Parasitol 2007 Jun;93(3):673-9 PMID:17626363 PubMed - indexed for MEDLINE

  45. Cancer cell injury by cytotoxins from cobra venom is mediated through lysosomal damage.
    Feofanov AV, Sharonov GV, Astapova MV, Rodionov DI, Utkin YN, Arseniev AS
    Biochem J 2005 Aug 15;390(Pt 1):11-8 PMID:15847607 PubMed - indexed for MEDLINE

  46. Cobra venom contains a pool of cysteine-rich secretory proteins.
    Osipov AV, Levashov MY, Tsetlin VI, Utkin YN
    Biochem Biophys Res Commun 2005 Mar 4;328(1):177-82 PMID:15670767 PubMed - indexed for MEDLINE

  47. Comparative study of structure and activity of cytotoxins from venom of the cobras Naja oxiana, Naja kaouthia, and Naja haje.
    Feofanov AV, Sharonov GV, Dubinnyi MA, Astapova MV, Kudelina IA, Dubovskii PV, Rodionov DI, Utkin YN, Arseniev AS
    Biochemistry (Mosc) 2004 Oct;69(10):1148-57 PMID:15527416 PubMed - indexed for MEDLINE

  48. A bradykinin potentiating peptide from Egyptian cobra venom strongly affects rat atrium contractile force and cellular calcium regulation.
    El-Saadani MA, El-Sayed MF
    Comp Biochem Physiol C Toxicol Pharmacol 2003 Dec;136(4):387-95 PMID:15012910 PubMed - indexed for MEDLINE

  49. Snake bite in Nigeria.
    Habib AG, Gebi UI, Onyemelukwe GC
    Afr J Med Med Sci 2001 Sep;30(3):171-8 PMID:14510123 PubMed - indexed for MEDLINE

  50. Cross neutralization of dangerous snake venoms from Africa and the Middle East using the VACSERA polyvalent antivenom. Egyptian Organization for Biological Products & Vaccines.
    Seddik SS, Wanas S, Helmy MH, Hashem M
    J Nat Toxins 2002 Dec;11(4):329-35 PMID:12503876 PubMed - indexed for MEDLINE
For Research Purposes Only - Not for Human Use

Privacy Statement | Ordering Informations | www.latoxan.com | www.biotoxan.com
Natural Active Ingredients - Venoms - Toxins - Alkaloids - Plant Compounds - Ion Channel & Receptor Ligands
LATOXAN SAS - Z.A. les Auréats, 845 Avenue Pierre Brossolette - 26800 PORTES-lès-VALENCE - France - Phone +33 475 419 191 - Fax +33 475 419 199 - www.latoxan.com
Optimised for Mozilla FireFox & Google Chrome (not for IE) - Copyright © Latoxan 2010
Last update : 2024-12-22 03:49:18